Martingale Asset Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,208
Closed -$290K 897
2021
Q3
$290K Buy
+17,208
New +$290K ﹤0.01% 760